BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17090024)

  • 1. Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe.
    Luo Y; Knuckley B; Bhatia M; Pellechia PJ; Thompson PR
    J Am Chem Soc; 2006 Nov; 128(45):14468-9. PubMed ID: 17090024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
    Slack JL; Causey CP; Luo Y; Thompson PR
    ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
    Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
    Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
    Knuckley B; Luo Y; Thompson PR
    Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
    Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
    Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.
    Luo Y; Knuckley B; Lee YH; Stallcup MR; Thompson PR
    J Am Chem Soc; 2006 Feb; 128(4):1092-3. PubMed ID: 16433522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a fluorescent probe for detection of citrulline based on photo-induced electron transfer.
    Kunieda K; Yamauchi H; Kawaguchi M; Ieda N; Nakagawa H
    Bioorg Med Chem Lett; 2018 Mar; 28(5):969-973. PubMed ID: 29439901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
    Bozdag M; Dreker T; Henry C; Tosco P; Vallaro M; Fruttero R; Scozzafava A; Carta F; Supuran CT
    Bioorg Med Chem Lett; 2013 Feb; 23(3):715-9. PubMed ID: 23265898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein arginine deiminase 4: evidence for a reverse protonation mechanism.
    Knuckley B; Bhatia M; Thompson PR
    Biochemistry; 2007 Jun; 46(22):6578-87. PubMed ID: 17497940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and in vitro evaluation of an activity-based protein profiling (ABPP) probe targeting agmatine deiminases.
    Thomson A; O'Connor S; Knuckley B; Causey CP
    Bioorg Med Chem; 2014 Sep; 22(17):4602-8. PubMed ID: 25127464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock?
    Thompson PR; Fast W
    ACS Chem Biol; 2006 Aug; 1(7):433-41. PubMed ID: 17168521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile fluorescence-based detection of PAD4-mediated citrullination.
    Wildeman E; Pires MM
    Chembiochem; 2013 May; 14(8):963-7. PubMed ID: 23640867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine.
    Li D; Liu C; Lin J
    J Mol Graph Model; 2015 Feb; 55():25-32. PubMed ID: 25424656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.
    Koushik S; Joshi N; Nagaraju S; Mahmood S; Mudeenahally K; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
    Expert Opin Ther Targets; 2017 Apr; 21(4):433-447. PubMed ID: 28281906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor.
    Tjin CC; Wissner RF; Jamali H; Schepartz A; Ellman JA
    ACS Med Chem Lett; 2018 Oct; 9(10):1013-1018. PubMed ID: 30344909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors.
    Trabocchi A; Pala N; Krimmelbein I; Menchi G; Guarna A; Sechi M; Dreker T; Scozzafava A; Supuran CT; Carta F
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):466-71. PubMed ID: 25198885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a highly sensitive fluorescence probe for peptidyl arginine deiminase (PAD) activity.
    Kunieda K; Kawaguchi M; Ieda N; Nakagawa H
    Bioorg Med Chem Lett; 2019 Apr; 29(7):923-928. PubMed ID: 30773431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence-based monitoring of PAD4 activity via a pro-fluorescence substrate analog.
    Sabulski MJ; Fura JM; Pires MM
    J Vis Exp; 2014 Nov; (93):e52114. PubMed ID: 25407913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity.
    Slack JL; Jones LE; Bhatia MM; Thompson PR
    Biochemistry; 2011 May; 50(19):3997-4010. PubMed ID: 21466234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis.
    Thirugnanasambandham I; Radhakrishnan A; Kuppusamy G; Kumar Singh S; Dua K
    Biochem Pharmacol; 2022 Jun; 200():115040. PubMed ID: 35436466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.